Abstract. Mortality associated with infections due to carbapenem-resistant Klebsiella pneumoniae (CR-KP) is high and the infections need to be predicted early. The risk factors for CR-KP infection are heterogeneous. The aim of the present study was to construct a model allowing for the early prediction of CR-KP infection. Nosocomial infections due to K. pneumoniae were evaluated retrospectively over a 2-year period. The case cohort consisted of 370 inpatients with CR-KP infection. For each case enrolled, two matched controls with no CR-KP infection during their hospitalization were randomly selected. Matching involved month of admission, ward, as well as interval days. The Vitek 2 system was used for identification of isolates and antimicrobial susceptibility testing. General linear model with logistic regression was used to identify possible risk factors. The predicted power of the model was expressed as the area under the receiver-operating characteristic curve. Age, male gender, with cardiovascular disease, hospital stay, recent admission to intensive care unit, indwelling urinary catheter, mechanical ventilation, recent β-lactam-β-lactamase inhibitors, fourth-generation cephalosporins and/or carbapenems therapy were independent risk factors for CR-KP infection. Models predicting CR-KP infection developed by cumulative risk factors exhibited good power, with areas under the receiver-operating characteristic curves of 0.902 [95% confidence interval (CI), 0.883-0.920; P<0.001] and 0.899 (95% CI, 0.877-0.921; P<0.001) after filtering by age (≥70 years). The Yonden index was at the maximum when the cumulative risk factors were ≥3 in the two prediction models. The results show that the prediction model developed in the present study might be useful for controlling infections caused by CR-KP strains.
Introduction
Infections caused by carbapenem-resistant Klebsiella pneumoniae (CR-KP) isolates are worldwide. The prevalence of CR-KP infection in areas of endemicity may vary between 20 and 40%. In addition, these infections often occur in debilitated and immunocompromised patients, in association with prolonged hospital stays (1) . The isolates are often resistant to multiple antibiotics, and the mortality associated with infections due to CR-KP is extremely high (2) (3) (4) . Early identification of possible CR-KP-infected patients and implementation of proper precaution are core measures for controlling CR-KP infections.
Risk factors involved in CR-KP infections have been previously investigated (5) (6) (7) (8) . These factors were heterogeneous. A retrospective study was conducted in a Chinese tertiary care hospital to identify the main factors associated with nosocomial CR-KP infections, and a model was established for the early prediction of patients with such infection. The results show that the prediction model developed in the present study might be useful for controlling infections caused by CR-KP strains.
Materials and methods
Setting and participants. The Beijing Shijitan Hospital of the Capital Medical University is a 1,100-bed tertiary care hospital in Beijing, China, with a 26-bed general intensive care unit (ICU), an 8-bed cardiology ICU, an 8-bed respiratory ICU, and a 6-bed emergency medicine ICU.
This retrospective study was conducted based on the hospital electronic database. During the 2-year study period (from January 1, 2012 to December 31, 2013), patients with K. pneumoniae nosocomial infection were evaluated. During the study period, rectal swab screening was not a routine admission procedure and patients were clustered within at least 48 h once CR-KP infection was confirmed.
In one hospitalization period, each patient was evaluated only once at the time of the index culture (nosocomial infections were validated by trained infection management doctors according to the criteria based on a previous study) (9) , and the index culture was defined with the K. pneumoniae strain first isolated from a clinical specimen and then the corresponding nosocomial infection was confirmed. Patients with CR-KP infections were defined as cases. For each case enrolled, two matched controls with no CR-KP infection during their hospitalization were randomly selected. Matching involved month of admission, ward, as well as interval days (interval from admission to confirmation of the index culture). The length of the entire hospital stay of the controls was equal or more to the interval days of the matched cases.
The following patient data were extracted: Age; gender; transfer from another hospital; comorbidity (at the time of index culture); recent admission to ICU (defined as patients admitted to ICU for >24 h before the index culture in one hospitalization period); with CR-KP-positive patients in nearby beds (defined as patients with CR-KP-positive patients in the same ward for >24 h before the index culture within the hospitalization period); adopted invasive procedures including central venous catheterization, urinary catheter, nasogastric tube, surgical drain, and invasive mechanical ventilation (at the time of the index culture); and on prior antibiotic therapy (defined as the use of a systemic antimicrobial agent for ≥48 h within the preceding 10 days of index culture in one hospitalization period).
Approval for the study was obtained from the ethics committee of the Beijing Shijitan Hospital of Capital Medical University.
Microbiological procedures. The Vitek 2 system (bioMérieux, Marcy l'Étoile, France) was used for identification of isolates and antimicrobial susceptibility testing. The production of extended-spectrum β-lactamases (ESBLs) was suggested following use of the Advanced Expert System of the Vitek 2 system. Susceptibility results to carbapenems (imipenem, meropenem, and ertapenem) were interpreted according to Clinical Laboratory Standards Institute guidelines coevally (i.e., susceptibility results of year 2012 were interpreted according to 2012 guideline and results of year 2013 were interpreted according to 2013 standards) (10) . Isolates were considered CR-KP if any of the carbapenems (ertapenem, meropenem, and imipenem) was resistant. If the carbapenem MIC of one isolate was intermediary, the isolate was excluded from the analysis.
Statistical analysis. The SPSS version 17.0 (SPSS, Inc., Chicago, IL, USA) software was used for data analysis. Non-normally distributed continuous variables were reported as medians (interquartile range); and numbers and percentages were reported for categorical variables. The Mann-Whitney U test was used to compare non-normally distributed continuous variables (i.e., ages). Categorical variables were evaluated with the Chi-square test.
The multivariate logistic regression model was used to adjust for potential confounding. Variables associated with CR-KP infection in the univariate analysis (P≤0.05) were included in a logistic regression analysis to identify those independently associated with the development of CR-KP nosocomial infection. Statistical tests were two-tailed. P≤0.05 was considered statistically significant.
The power of age and cumulative risk factors to discriminate cases and controls were expressed as the area under the receiver-operating characteristic curve.
Results

Characteristics of isolates.
During the 2-year study period, 370 non-repetitive episodes of nosocomial infections due to CR-KP were found. The characteristics of the cases and controls are shown in Table I . The median (IQR) time of interval days in the case cohort was 17 days (13-21 days). No active outbreak of CR-KP during the 2-year study period was recorded.
CR-KP isolates were recovered from the sputum/bronchoalveolar lavage fluid (n=268), urine (n=48), blood (n=35), skin/mucosa (n=10), surgical site (n=7), and cerebrospinal fluid (n=2). ESBLs were produced by 61% of CR-KP strains (n=225).
Risk factors associated with CR-KP infection.
The main findings of the univariate and multivariate analysis associated with CR-KP infection are shown in Table I . The multivariate analysis revealed that age, male gender, with cardiovascular disease, recent admission to ICU, indwelling urinary catheter and/or surgical drain, mechanical ventilation, and prior administration of β-lactam-β-lactamase inhibitors, fourth-generation cephalosporins, and/or carbapenems were significantly different between CR-KP infections and controls.
Cumulative risk factors and their predicting power of CR-KP infection.
Male gender, with cardiovascular disease, recent admission to ICU, indwelling urinary catheter, mechanical ventilation, and prior use of antibiotics of β-lactam-β-lactamase inhibitors, fourth-generation cephalosporins and/or carbapenems were included in the calculation of cumulative risk factors (Table II) .
The area under the curve (AUC) was 0.739 (95% CI, 0.709-0.768; P≤0.001) for age prediction CR-KP infection. The Yonden index was at its maximum when the patient age was 70 years. After filtering by age (≥70 years), 338 CR-KP infection cases and 437 controls remained.
The sensitivity, specificity, and total consistency rate for predicting CR-KP infection at different cut-off levels using cumulative risk factors are shown in Table III . The AUC was 0.902 (95% CI, 0.883-0.920; P≤0.001) for cumulative risk factors predicting CR-KP infection tested in the total 1,110 patients and 0.899 (95% CI, 0.877-0.921; P≤0.001) tested in the 775 patients filtered by age (Fig. 1) , respectively. The Yonden index was at its maximum when the cumulative risk factors were ≥3 in the two prediction models. However, the sensitivity of prediction increased from 84.8 to 85.2% and the specificity increased from 68.1 to 81.2% with age (≥70 years), respectively.
Discussion
The results of the present study showed that age, male gender, with cardiovascular disease, recent admission to ICU for more than 24 h, indwelling urinary catheter, mechanical ventilation, exposure to β-lactam-β-lactamase inhibitors, fourth-generation cephalosporins and carbapenems were associated with CR-KP infection.
Compared with young patients, elderly patients were more likely to have comorbidities and susceptibility to infections (11) . In the present study, patients with CR-KP infection were elderly compared to those with no CR-KP infection.
Male gender was associated with CR-KP infection. Daikos et al found that the proportion of male patients surviving was significantly higher than those that succumbed due to carbapenemase-producing K. pneumoniae bloodstream infections (2) . However, to the best of our knowledge, this is the first time that the male gender and cardiovascular disease constituted risk factors for CR-KP infection. Regarding the latter, it may be explained by the fact that cardiovascular disease is diagnosed more frequently in men (12) .
As expected, ICU stay was an independent risk factor for CR-KP infections. ICUs are the principal hospital reservoirs of MDR bacteria. Patients with ICU admission represent a population subjected to many invasive procedures and medical devices, which facilitate cross-transmission of resistance mechanisms (7,13,14) . f Including semisynthetic penicillins, oxyimino-cephalosporins, glycopeptides, linezolid, rifampin, erythromycins, and antifungal drugs.
Univariate analysis Multivariate analysis ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
In the current study, CR-KP infection was also associated with indwelling urinary catheter and mechanical ventilation. These invasive procedures are well-known risk factors for MDR bacteria infection/colonization (7, 13, 15) .
Prior administration of β-lactam-β-lactamase inhibitors and/or carbapenems was associated with CR-KP infection, as reported in other studies (7, 8, 16 ). This observation may be due to the fact that treatment with broad-spectrum antibiotics potentially promotes the selection of CR-KP strains by eliminating susceptible competing clones. In a previous study, it was reported that a combination therapy containing carbapenem was strongly associated with survival in CR-KP bloodstream infections (2) . Thus, administration of carbapenem should be used prudently in empirical therapy, and once the CR-KP infection is highly suspected or verified, a regimen including carbapenem is likely to benefit the outcome.
Previous findings have shown that the presence of CR-KP-colonized patients in nearby beds was associated with CR-KP infection/colonization (17, 18) . In the present study, although the proportion of patients who had CR-KP-positive Total   b   0  4  154  158  4  93  97  1  13  279  292  11  160  171  2  39  171  210  35  102  137  3  76  94  170  71  54  125  4  86  29  115  86  19  105  5  86  13  99  71  9  80  6  66  0  66  60  0  60  7  0  0  0  0  0  0  Total  370 patients in nearby beds was higher in the case group than in the control group, CR-KP-positive patients in nearby beds was not an independent risk factor of CR-KP infection. This discrepancy may partly be because of the different case-control design, and remains to be confirmed.
The model for predicting CR-KP infection developed in this study displayed good discriminatory power (AUC= 0.902), which is similar to the model developed by Tumbarello et al (7) . The sensibility was 84.8% and specificity was 68.1% when there were three or more risk factors for predicting CR-KP infection. The age of patients (≥70 years) increased the predicting specificity to 81.2%. The predicting model is potentially useful in hospitals where CR-KP infection is epidemic. Empirical application of infection control measures, such as rectal swabs, may be limited to individuals with a higher possibility of CR-KP infection, thereby reducing workloads and costs. This prediction model may also be useful for empirical antimicrobial therapy and potentially reduce the risk of ineffective therapy during the initial phase of treatment. Notably, the prevention of nosocomial acquisition of resistant bacteria is dependent on implementation of and adherence to infection control standards.
In conclusion, the present findings provide information that may be useful for identifying patients at high risk for CR-KP infection and may assist physicians to use more effective treatments for CR-KP infections.
